Krsnaa Diagnostics - Full Form of Employee
Krsnaa Diagnostics - Full Form of Employee
Krsnaa Diagnostics - Full Form of Employee
FORM FOR ELIGIBLE Registered and Corporate Office: S.No. 243/A, Hissa No. 6, CTS No. 4519, 4519/1, Near Chinchwad Station, Chinchwad,
EMPLOYEES BIDDING Taluka – Haveli, Pune - 411 019, Maharashtra; Telephone: +91 20 4695 4695 BIDDING IN THE EMPLOYEE
UNDER EMPLOYEE Contact Person: Manisha Chitgopekar, Company Secretary and Compliance Officer; Telephone: +91 20 4695 4695; RESERVATION PORTION
RESERVATION PORTION E-mail: cs@krsnadiagnostics.com; Website: www.krsnaadiagnostics.com; Corporate Identity Number: U74900PN2010PLC138068
TEAR HERE
Mr. /Ms./M/s.
SUB-BROKER’S / SUB-AGENT’S STAMP & CODE SCSB BRANCH STAMP & CODE
Address
Email
BANK BRANCH SERIAL NO. SCSB SERIAL NO. Tel. No. (with STD code) / Mobile
2. PAN of SOLE / FIRST BIDDER
For NSDL enter 8 digit DP ID followed by 8 digit Client ID / For CDSL enter 16 digit Client ID
4. Bid Options (ELIGIBLE EMPLOYEES BIDDING IN THE EMPLOYEE RESERVATION PORTION can Bid at “Cut-off”) 5. Category 6. Investor Status
No. of Equity Shares Bid (In Figures) Price per Equity Share (`)/ “Cut-off”
Eligible Employees - EMP
(Bids must be in multiples of (Price in multiples of ` 1 only) (In Figures only)
Bid Bid Lot as advertised)
Options Bid Price Employee Discount Net Price “Cut-off” Directors of Company - DIR
8 7 6 5 4 3 2 1 3 2 1 3 2 1 3 2 1 (Pleasetick)
Eligible Employee Code / Number
Option 1 Employee
(OR) Option 2
__________________________
Please Fill in Block Letters
(OR) Option 3
ASBA
Bank A/c No.
I/We (on behalf of joint BIDDERS, if any) hereby confirm that I/We have read and understood the terms and conditions of this COMMON Bid Cum Application
Form, the attached ABRIDGED PROSPECTUS AND THE GENERAL INFORMATION DOCUMENT FOR INVESTING IN PUBLIC ISSUES (“GID”) and hereby agree and confirm the
‘Bidder’s Undertaking’ as given OVERLEAF. I/We (on behalf of joint BIDDERS, if any) hereby confirm that I/We have read the Instructions for filling up the
COMMON Bid Cum Application Form given overleaf.
8B. signature OF ASBA BANK ACCOUNT HOLDER(s) MEMBERs OF the SYNDICATE / SUB - SYNDICATE
8A. signature OF SOLE/ first BIDDER MEMBER / R E G I S T E R E D B roker / SCSB / CDP /
(As per Bank records) RTA / Agent STAMP (Acknowledging upload of
I/We authorise the SCSB to do all acts as are necessary to make the application in the Offer. Bid in Stock Exchange system)
1)
2)
Amount blocked (` in figures) ASBA Bank A/c No. Stamp & Signature of SCSB Branch
Bank Name & Branch
Stamp & Signature of Members of the Syndicate / sub-syndicate Name of Sole / First Bidder
Option 1 Option 2 Option 3
EMPLOYEES BIDDING IN THE EMPLOYEE
Bid Price
Amount Blocked (` in figures) Acknowledgement Slip for Bidder
TEAR HERE
● In case of queries related to Allotment/ credit of Allotted Equity COMPANY contact details Registrar to the Offer contact details
Shares, the Bidders should contact Registrar to the Offer. Krsnaa Diagnostics Limited Kfin Technologies Private Limited
Registered and Corporate Office: S.No. 243/A, Hissa No. 6, Selenium Tower B, Plot 31 & 32, Gachibowli Financial District,
● In case of Bids submitted to the SCSBs, the Bidders should CTS No. 4519, 4519/1, Near Chinchwad Station, Nanakramguda, Serilingampally, Hyderabad 500 032
contact the relevant SCSB. Chinchwad, Taluka – Haveli, Pune - 411 019, Maharashtra; Telangana; Telephone: +91 40 6716 2222
Telephone: +91 20 4695 4695 Email: krsnaa.ipo@kfintech.com
● In case of queries related to upload of Bids submitted to the Contact Person: Manisha Chitgopekar, Company Secretary and Website: www.kfintech.com/
relevant members of the Syndicate / RTAs / Registered Brokers Compliance Officer; Telephone: +91 20 4695 4695; Investor grievance e-mail: einward.ris@kfintech.com
/ CDPs, as applicable, the Bidders should contact the relevant E-mail: cs@krsnadiagnostics.com; Contact person: M. Murali Krishna
Designated Intermediary. Website: www.krsnaadiagnostics.com; SEBI registration no.: INR000000221
Corporate Identity Number: U74900PN2010PLC138068
This is an abridged prospectus containing salient features of the red herring prospectus dated July 29, 2021 (the “RHP”) and the Preliminary
Offering Memorandum dated July 29, 2021. You are encouraged to read greater details available in the RHP. Unless otherwise specified all
capitalized terms used herein and not specifically defined shall have the same meaning as ascribed to them in the RHP.
THIS ABRIDGED PROSPECTUS CONSISTS OF FOUR PAGES OF BID CUM APPLICATION FORM ALONGWITH INSTRUCTIONS
AND SIX PAGES OF ABRIDGED PROSPECTUS. PLEASE ENSURE THAT YOU HAVE RECEIVED ALL THE PAGES.
Please ensure that you have read the RHP, this Abridged Prospectus and the general information document (“GID”) for investing in public issues undertaken through the Book Building Process
before applying in the Offer (as defined below). You may obtain a physical copy of the Bid-cum-Application Form and the RHP from the Stock Exchanges (as defined below), Members of the
Syndicate, Registered Brokers, Collecting Depository Participants (“CDPs”), Registrar to the Offer, Registrar and Share Transfer Agents (“RTAs”), Banker to the Offer, Investors’ Associations
or Self Certified Syndicate Banks (“SCSBs”). You may also download the RHP from the websites of the Securities and Exchange Board of India (“SEBI”) at www.sebi.gov.in, the Stock Exchanges
where the Equity Shares (as defined below) are proposed to the listed, i.e., BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE” or “Designated Stock Exchange” and
together with BSE, the “Stock Exchanges”) at www.bseindia.com and www.nseindia.com, respectively and the Book Running Lead Managers (“BRLMs”) at www.jmfl.com, www.damcapital.in,
www.equirus.com and www.iiflcap.com.
This Abridged Prospectus may only be accessed by investors outside of India that have read the Preliminary Offering Memorandum of the Company dated July 29, 2021, a copy of which is
available to eligible investors from the BRLMs.
INDICATIVE TIMELINE
BID/OFFER OPENS ON* Wednesday, Initiation of refunds (if any, for Anchor Investors) / On or about Thursday,
August 04, 2021 unblocking of funds from ASBA Account*** August 12, 2021
BID/OFFER CLOSES ON** $ Credit of Equity Shares to demat accounts of Allottees On or about Friday,
Friday, August 06, 2021
August 13, 2021
Finalisation of Basis of Allotment with On or about Wednesday, Commencement of trading of the Equity Shares on On or about Tuesday,
the Designated Stock Exchange August 11, 2021 the Stock Exchanges August 17, 2021
*Our Company and the Selling Shareholders may, in consultation with the BRLMs, allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary
basis, in accordance with the SEBI ICDR Regulations. Anchor Investors shall Bid on the Anchor Investor Bidding Date.**Our Company and the Selling
Shareholders may, in consultation with the BRLMs, consider closing the Bid/Offer Period for QIBs one day prior to the Bid/Offer Closing Date in accordance
with the SEBI ICDR Regulations. $UPI mandate end time and date shall be at 12.00 p.m. on August 9, 2021. ***In case of any delay in unblocking of amounts in
the ASBA Accounts (including amounts blocked through the UPI Mechanism) exceeding four Working Days from the Bid/Offer Closing Date, the Bidder shall be
compensated at a uniform rate of ₹100 per day for the entire duration of delay exceeding four Working Days from the Bid/Offer Closing Date by the intermediary
responsible for causing such delay in unblocking. The BRLMs shall, in their sole discretion, identify and fix the liability on such intermediary or entity responsible
for such delay in unblocking. The BRLMs shall, in their sole discretion, identify and fix the liability on such intermediary or entity responsible for such delay in
unblocking. For the avoidance of doubt, the provisions of the SEBI circular no. SEBI/HO/CFD/DIL1/CIR/P/2021/47 dated March 31, 2021, March 2021 Circular,
as amended pursuant to June 2021 Circular shall be deemed to be incorporated in the agreements to be entered into by and between the Company and the relevant
intermediaries, to the extent applicable.
GENERAL RISKS
Investments in equity and equity-related securities involve a degree of risk and investors should not invest any funds in the Offer unless they can
afford to take the risk of losing their investment. Investors are advised to read the risk factors carefully before taking an investment decision in
the Offer. For taking an investment decision, investors must rely on their own examination of our Company and the Offer, including the risks
involved. The Equity Shares in the Offer have not been recommended or approved by the Securities and Exchange Board of India (“SEBI”),
nor does SEBI guarantee the accuracy or adequacy of the contents of the Red Herring Prospectus. Specific attention of the investors is invited
to “Risk Factors” on page 24 of the RHP and “Internal Risk Factors” on page 8 of this Abridged Prospectus.
PRICE INFORMATION OF BRLMs
S. Issue Name Name of the Merchant +/- % change in closing +/- % change in closing +/- % change in closing
No. Banker price, [+/- % change in price, [+/- % change in price, [+/- % change in
closing benchmark]- closing benchmark]- closing benchmark]-
30th calendar days from 90th calendar days from 180th calendar days
listing listing from listing
1 Clean Science and Technology Limited JM Financial NA NA NA
2 India Pesticides Limited JM Financial NA NA NA
3 Shyam Metalics and Energy Limited JM Financial, IIFL Securities 40.95% [0.42%] NA NA
4 Sona BLW Precision Forgings Limited JM Financial 45.45% [0.42%] NA NA
5 Macrotech Developers Limited JM Financial, IIFL Securities 30.22% [5.21%] 75.43% [10.89%] NA
6 Anupam Rasayan India Limited8 JM Financial, IIFL Securities -0.11% [-0.98%] 30.49% [8.23%] NA
7 Easy Trip Planners Limited JM Financial -7.27% [-0.86%] 124.68% [6.94%] NA
8 Mazagon Dock Shipbuilders Limited JM Financial, DAM Capital +18.90% [+5.87%] +52.90% [+20.25%] +45.79% [+24.34%]
9 Indian Railway Finance Corporation Limited DAM Capital -5.19% [+6.56%] -18.65% [+9.02%] -11.15% [+15.49%]
10 Laxmi Organic Industries Limited DAM Capital +37.85% [+0.11%] +71.96% [+10.11%] NA
11 Antony Waste Handling Cell Limited Equirus, IIFL Securities -10.27% [-2.74%] -23.21% [+4.80%] 2.14% [12.34%]
12 Craftsman Automation Limited IIFL Securities -13.82% [+0.11%] +16.81% [+10.11%] NA
13 Suryoday Small Finance Bank Ltd IIFL Securities -18.38% [-1.14%] -26.87% [-98.46%] NA
14 Nazara Technologies Ltd IIFL Securities +62.57% [0.13%] +38.22% [6.84%] NA
15 Barbeque-Nation Hospitality Limited IIFL Securities +18.77% [-0.64%] +76.97% [+6.85%] NA
16 Krishna Institute of Medical Sciences Limited IIFL Securities +48.10% [-0.43%] NA NA
17 G R Infrastructure Limited Equirus NA NA NA
Disclosures subject to recent 7 issues (initial public offerings) in current financial year and two preceding financial years managed by each BRLM
with common issues disclosed once.
For further details, please refer to price information of past issues handled by Managers on pages 339 to 342 of the RHP.
BOOK RUNNING LEAD MANAGERS
JM Financial Limited DAM Capital Advisors Limited Equirus Capital Private Limited IIFL Securities Limited
Tel.: : +91 22 6630 3030 (Formerly IDFC Securities Limited) Tel.: +91 22 4332 0700 Tel.: +91 22 4646 4600
E-mail: krsnaadiagnostics.ipo@jmfl.com Tel.: +91 22 4202 2500 E-mail: krsnaa.ipo@equirus.com E-mail: krsnaa.ipo@iiflcap.com
Investor grievance e-mail: E-mail: krsnaa.ipo@damcapital.in Investor grievance e-mail: Investor grievance e-mail:
grievance.ibd@jmfl.com Investor grievance e-mail: investorsgrievance@equirus.com ig.ib@iiflcap.com
complaint@damcapital.in
4 KRSNAA DIAGNOSTICS LIMITED
IN THE NATURE OF ABRIDGED PROSPECTUS - MEMORANDUM CONTAINING SALIENT FEATURES OF THE RED HERRING PROSPECTUS
Name of Syndicate Member: Equirus Securities Private Limited, JM Financial Services Limited and Sharekhan Limited
Registrar to the Offer: KFin Technologies Private Limited
Tel: +(91) 40 6716 2222
E-mail: krsnaa.ipo@kfintech.com
Investor grievance e-mail: einward.ris@kfintech.com
Statutory Auditor: MSKA & Associates
Name of Credit Rating Not Applicable
Agency and grading
obtained, Debenture Trustee
Self Certified Syndicate The list of SCSBs notified by SEBI for the ASBA process is available at http://www.sebi.gov.in/sebiweb/
Banks: other/OtherAction.do?doRecognised=yes, or at such other website as may be prescribed by SEBI from time to
time. A list of the Designated SCSB Branches with which an ASBA Bidder (other than a RIB using the UPI
Mechanism), not bidding through Syndicate/Sub Syndicate or through a Registered Broker, RTA or CDP may
submit the Bid cum Application Forms, is available at https://www.sebi.gov.in/sebiweb/other/OtherAction.do?d
oRecognisedFpi=yes&intmId=34, or at such other websites as may be prescribed by SEBI from time to time.
In accordance with SEBI Circular No. SEBI/HO/CFD/DIL2/CIR/P/2019/76 dated June 28, 2019 and SEBI
Circular No. SEBI/HO/CFD/DIL2/CIR/P/2019/85 dated July 26, 2019, Retail Individual Investors Bidding
using the UPI Mechanism may apply through the SCSBs and mobile applications whose names appears on
the website of SEBI (https://www.sebi.gov.in/sebiweb/other/OtherAction.do?doRecognisedFpi=yes&intmId=40)
and (https://www.sebi.gov.in/sebiweb/other/OtherAction.do?doRecognisedFpi=yes&intmId=43) respectively, as
updated from time to time.
Non Syndicate Registered Bidders can submit ASBA Forms in the Offer using the stock broker network of the stock exchange, i.e. through
Brokers: the Registered Brokers at the Broker Centres. The list of the Registered Brokers, including details such as postal
address, telephone number and e-mail address, is provided on the websites of the Stock Exchanges at https://www.
bseindia.com/ and https://www.nseindia.com, or any such websites of the Stock Exchanges, as updated from time
to time.
Details regarding website The list of the Registered Brokers is provided on the websites of BSE and NSE at www.bseindia.com and www.
address(es)/ link(s) from nseindia.com respectively, or such other website as updated from time to time. The list of the RTAs eligible to
which the investor can obtain accept ASBA Forms at the Designated RTA Locations, is provided on the websites of Stock Exchanges at http://
a list of RTAs, CDPs and www.bseindia.com/Static/Markets/PublicIssues/RtaDp.aspx? and http://www.nseindia.com/products/content/
stock brokers who can accept equities/ipos/asba_procedures.htm, respectively, as updated from time to time. The list of the CDPs eligible to
applications from investors, accept ASBA Forms at the Designated CDP Locations, is provided on the websites of BSE at http://www.bseindia.
as applicable: com/Static/Markets/PublicIssues/RtaDp.aspx? and on the website of NSE at http://www.nseindia.com/products/
content/equities/ipos/asba_procedures.htm, as updated from time to time. For further details, see “Offer Procedure”
on page 355 of the RHP.
PROMOTER OF OUR Company
Rajendra Mutha is the promoter of the Company and is also the Executive Chairman of our Board of Directors and Whole-time Director of
our Company. He has been associated with our Company since incorporation and has over 10 years of experience in the field of pharmacy
and diagnostics. He is currently responsible for the overall management of the Company. For details in respect of their date of birth, age,
personal address, educational qualifications, experience in the business, positions and posts held in the past, business and financial activities,
other directorships, see “Our Management” and “Our Promoters and Promoter Group” beginning on page 177 and page 196 respectively,
of the RHP.
Our BUSINESS OVERVIEW AND STRATEGY
We are one of the largest differentiated diagnostic service provider in India (Source: CRISIL Report). We provide a range of technology-
enabled diagnostic services such as imaging (including radiology), pathology/clinical laboratory and tele-radiology services to public and private
hospitals, medical colleges and community health centres pan-India. We are the fastest growing diagnostic chain in India on multiple parameters
including operating income, operating profit before depreciation, interest and tax (“OPBDIT”) and profit after tax between Fiscal 2017 and
Fiscal 2020 and volume of tests conducted between Fiscal 2018 and Fiscal 2021 (amongst players with revenues exceeding ₹1,500 million)
(Source: CRISIL Report). According to CRISIL Report, we also operate one of India’s largest tele-radiology reporting hubs in Pune that is
able to process large volumes of X-rays, CT scans and MRI scans round the clock and 365 days a year, and allows us to serve patients in
remote locations where diagnostic facilities are limited. We provide quality and inclusive diagnostic services at affordable rates across various
segments. Since inception, we have served more than 23 million patients.
Our strengths: 1) Unique and scaled diagnostics company. 2) Strong brand equity. 3) Extensive footprint across India with robust infrastructure. 4)
Business model with robust revenue visibility. 5) Well positioned to capitalize on healthcare spending across public and private sectors. 6) Scalable
and agile business model with efficient cost structure. 7) Consistent track record of financial performance. 8) Ability to maintain cost competitiveness
through operating leverage 9) Experienced promoters and management team supported by strong employee base.
Our strategies: 1) Continue to expand presence across India. 2) Expand our offering of diagnostic services with a focus on specialized diagnostics
3) Grow our digital footprint. 4) Maintain high social impact. 5) Continue to improve profitability and efficiency. 6) Expand our business and geographical
footprint through opportunistic acquisitions.
KRSNAA DIAGNOSTICS LIMITED 5
IN THE NATURE OF ABRIDGED PROSPECTUS - MEMORANDUM CONTAINING SALIENT FEATURES OF THE RED HERRING PROSPECTUS
Board of Directors
Sr. No. Name Designation Experience including current/past position held in other firms
1. Rajendra Mutha Executive He is a registered pharmacist certified by the Maharashtra State Pharmacy Council. He has been
Chairman and associated with our Company since incorporation and has over 10 years of experience in the
Whole-time field of pharmacy and diagnostics. He is currently responsible for the overall management of the
Director Company. He is also a director of Krsna Diagnostics (Mumbai) Private Limited.
2. Pallavi Bhatevara Managing She has passed the higher secondary exams from the Maharashtra State Board of Secondary
Director and Higher Secondary Education. She has been associated with our Company since January
29, 2013 and has 8 years of experience in the field of diagnostic services. She is currently
responsible for expansion and growth of our Company and is involved in the tendering process
and implementation and execution of projects.
3. Yash Mutha Whole-time He holds a bachelor’s degree in commerce from the University of Pune and has been admitted
Director to the Institute of Chartered Accountants of India as an associate member. He is also a certified
fraud examiner and has been accredited by Association of Certified Fraud Examiners, USA
and a Certified Information Systems Auditor (“CISA”) accredited by the CISA Certification
Committee, USA. He has been associated with our Company since October 17, 2018. He has
over 12 years of experience in the field of audit and risk management. He has been previously
associated with BSR & Co. LLP, Deloitte, KPMG and Credit Suisse Services (India) Private
Limited. He also serves as director on board of Proximit Media India Private Limited.
4. Prem Pradeep Non-Executive He holds a bachelor’s degree in mechanical engineering from the Indian Institute of Technology
Nominee Director and master’s degree in management from the Indian Institute of Management. He has been
associated with our Company since October 8, 2020. He has experience in the field of operations
and execution. Prior to joining our Company, he was associated with TVS Interconnect Systems
Limited as president and CEO and thereafter Executive Director, and Bharti Infratel Limited
as Chief Executive Officer. He is currently associated with Phi Capital Management LLP as an
Operating Partner. He is also a director of TVS Sensing Solutions Private Limited.
5. Chhaya Palrecha Non-Executive She holds a bachelor’s degree in commerce from the University of Pune and is a member of
Independent the Institute of Chartered Accountants of India. She also holds the diploma in international
Director financial reporting from the Association of Chartered Certified Accountants. Prior to joining
our Company, she was associated with Prasanna Purple Mobility Solutions Private Limited as
the chief financial officer. She also serves as a director of 5 other Indian companies, including
Garware Bestretch Limited, Quickfind Online Services Private Limited and Universal Sompo
General Insurance Company Limited.
6. Chetan Desai Non-Executive He is a fellow member of the Institute of Chartered Accountants of India. He has over 46 years
Independent of experience as a chartered accountant and was associated with M/s. Haribhakti & Co. LLP., as
Director managing partner. He also holds directorships of 12 other Indian Companies, including Angel
Xpress Foundation, Brookfield India Infrastructure Manager Private Limited and Reliance
Securities Limited.
7. Prakash Iyer Non-Executive He holds a master’s degree in management from the Indian Institute of Management, Ahmedabad.
Independent Prior to joining our Company, he was associated with Kimberly-Clark Lever Private Limited as
Director managing director, India. He is also a director of Livpure Private Limited.
8. Rajiva Ranjan Verma Non-Executive He passed the intermediate examination in science held by Patna University and a bachelor’s
Independent degree in law from the Bhagalpur University. He is an erstwhile Indian police service officer
Director associated with Bihar police and has held positions such as of director of national crime records
bureau, director general of the Railway Protection Force, Government of India prior to joining
our Company. He is also a recipient of the president’s police medal. He was associated with Tata
Power Company Limited as chief of security, vigilance and corporate relations.
For further details in relation to our Board of Directors, see “Our Management” beginning on page 177 of the RHP.
OBJECTS OF THE OFFER
The Offer comprises of the Fresh Issue by our Company and the Offer for Sale by the Selling Shareholders.
Offer for Sale: Each of the Selling Shareholders will be entitled to the respective portion of the proceeds of the Offer for Sale, after deducting
their portion of the Offer related expenses and relevant taxes thereon. Our Company will not receive any proceeds from the Offer for Sale. All
expenses in relation to the Offer other than the listing fees (which shall be borne by our Company) shall be shared among our Company and
the Selling Shareholders on a pro rata basis, in proportion to the Equity Shares Allotted by our Company in the Fresh Issue and the respective
portion of the Offered Shares sold by each Selling Shareholder in the Offer for Sale, in accordance with applicable law. Please see “Objects of
the Offer - Offer Related Expenses” section on page 105 of the RHP.
Fresh Issue: The net proceeds of the Fresh Issue (“Net Proceeds”) are proposed to be utilised in the following manner::
1. Proposing to finance the cost of establishing diagnostics centres at Punjab, Karnataka, Himachal Pradesh and Maharashtra.;
2. Repayment/pre-payment, in full or part, of borrowings from banks and other lenders availed by our Company; and
3. General corporate purposes.
6 KRSNAA DIAGNOSTICS LIMITED
IN THE NATURE OF ABRIDGED PROSPECTUS - MEMORANDUM CONTAINING SALIENT FEATURES OF THE RED HERRING PROSPECTUS
Net Proceeds: The details of the proceeds from the Fresh Issue are provided in the following table:
(` in million)
Particulars Estimated amount
Gross proceeds from the Fresh Issue 4,000*
Less: Offer related expenses to be borne by the Company** [●]
Net Proceeds [●]
*Subject to full subscription of the Fresh Issue component
**For further details, see “Objects of the Offer – Offer related expenses” on page 105 of the RHP..
Utilization of Net Proceeds and Schedule of Implementation and Deployment:
The Net Proceeds are proposed to be used in accordance with the details provided in the following table: (` in million)
Particulars Total estimated Estimated Estimated schedule of deployment of
amount/ utilisation from Net Net Proceeds in
expenditure Proceeds(1) Fiscal 2022 Fiscal 2023
Finance the cost of establishing diagnostics centres at 1,508.10 1,508.10 1,250.00 258.10
Punjab, Karnataka, Himachal Pradesh and Maharashtra
Repayment/pre-payment, in full or part, of borrowings 1,460.81 1,460.81 1,460.81 Nil
from banks and other lenders availed by our Company
General corporate purposes (2) [●] [●] [●] [●]
(1) To be finalised upon determination of the Offer Price and updated in the Prospectus prior to filing with the RoC.
(2) The amount utilised for general corporate purposes shall not exceed 25% of the Gross Proceeds
Means of finance: The objects of the Offer shall be financed entirely from the Net Proceeds and no debt shall be incurred to finance any
component of such objects. Therefore, the requirements of the SEBI ICDR Regulations to make firm arrangements through verifiable means of
the stated means of finance are not applicable to the Offer.
Details and reasons for non-deployment or delay in deployment of proceeds or changes in utilisation of issue proceeds of past public issues /
rights issues, if any, of the Company in the preceding 10 years: Not Applicable
Terms of Issuance of Convertible Security, if any: Not Applicable
Name of Monitoring Agency: ICICI Bank Limited
Shareholding Pattern as on the date of the RHP:
Category of shareholder Number of fully paid up equity shares held Shareholding as a % of total number of shares
Promoter and Promoter Group 8,597,676 31.62
Public 18,593,852 68.38
Non Promoter- Non Public - -
Total 27,191,528 100.00%
Number of Equity Shares proposed to be sold by Selling Shareholders:
Sr. No. Name of Selling Shareholder Total number of Offered Shares
1. Phi Capital 1,600,000
2. Kitara 3,340,713
3. Somerset 3,563,427
4. Lotus Management Solutions (acting through and represented by Mayur Sirdesai) 21,380
Total 8,525,520
RESTATED AUDITED FINANCIAL STATEMENTS
(` in million expect if stated otherwise)
For the Fiscal For the Fiscal For the Fiscal
Particulars ended March 31, 2021 ended March 31, 2020 ended March 31, 2019
Revenue from Operations 3,964.56 2,584.27 2,092.35
Profit/(Loss) Before Tax 2,954.52 (1,583.32) (777.26)
Profit/(Loss) for the period / year 1,849.29 (1,119.51) (580.57)
Equity Share Capital 64.95 51.63 51.63
Instruments entirely equity in nature 2,423.90 150.24 150.24
Other Equity (170.20) (2,171.64) (1,051.08)
Net Worth 2,318.65 (1,969.77) (849.21)
Basic EPS (in `)* 71.86 (43.53) (24.13)
Diluted EPS (in `)* 12.25 (43.53) (24.13)
Return on Net Worth (%) 79.76% (56.83%) (68.37%)
Net asset value per share (`)* 85.27 (76.56) (33.00)
*post conversion of Preference Shares and Split
KRSNAA DIAGNOSTICS LIMITED 7
IN THE NATURE OF ABRIDGED PROSPECTUS - MEMORANDUM CONTAINING SALIENT FEATURES OF THE RED HERRING PROSPECTUS
Offer structure
Particulars QIBs (1) Non-Institutional Investors Retail Individual Investors Eligible Employees
Number of Equity Shares Not less than [●] Equity Shares or the Net Offer less allocation to RIIs Not more than [●] Equity Shares Not more than [●] Equity Shares Up to [●] Equity Shares aggregating up to
available for Allotment/ and NIIs subject to the Allocation/Allotment of not less than 75% of the ₹200.00 million
allocation* (2) Net Offer.
Percentage of Offer Size Not less than 75% of the Net Offer shall be available for allocation to Not more than 15% of the Net Offer. Not more than 10% of the Net Offer. The Employee Reservation Portion shall
available for Allotment/ QIB Bidders. constitute up to [●]% of the post-Offer paid-up
allocation However, up to 5% of the Net QIB Portion shall be available for allocation Equity Share capital of our Company
proportionately to Mutual Funds only. Mutual Funds participating in the
5% reservation in the Net QIB Portion will also be eligible for allocation in
the remaining QIB Portion. The unsubscribed portion in the Mutual Fund
reservation will be available for allocation to QIBs.
Basis of Allotment/ Proportionate as follows (excluding the Anchor Investor Portion): Proportionate Proportionate, subject to the minimum Bid Lot. Proportionate; unless the Employee
allocation if respective (a) up to [●] Equity Shares shall be available for allocation on a The allotment to each Retail Individual Investor Reservation Portion is undersubscribed, the
category is oversubscribed* proportionate basis to Mutual Funds only; and shall not be less than the minimum Bid Lot, value of allocation to an Eligible Employee
(b) [●] Equity Shares shall be Allotted on a proportionate basis to all QIBs, subject to availability of Equity Shares in the shall not exceed ₹200,000. In the event of
including Mutual Funds receiving allocation as per (a) above Retail Portion and the remaining available Equity undersubscription in the Employee Reservation
Shares if any, shall be allotted on a proportionate Portion, the unsubscribed portion may be
Our Company in consultation with the BRLMs, may allocate up to 60%
basis. For details, see “Offer Procedure” on page allocated, on a proportionate basis, to Eligible
of the QIB Portion to Anchor Investors at the Anchor Investor Allocation
355 of the RHP. Employees for a value exceeding ₹200,000 up
Price on a discretionary basis, out of which at least one-third will be
to ₹500,000 each
available for allocation to Mutual Funds only subject to valid Bid received
from Mutual Funds.
Minimum Bid Such number of Equity Shares in multiples of [●] Equity Shares, that the Such number of Equity Shares that the Bid [●] Equity Shares [●] Equity Shares
Bid Amount exceeds ₹200,000 Amount exceeds ₹200,000 and in multiples of
[●] Equity Shares thereafter
Maximum Bid Such number of Equity Shares in multiples of [●] Equity Shares not Such number of Equity Shares in multiples of Such number of Equity Shares in multiples of [●] Such number of Equity Shares and in multiples
exceeding the size of the Net Offer, subject to applicable limits [●] Equity Shares not exceeding the size of the Equity Shares so that the Bid Amount does not of [●] Equity Shares so that the maximum Bid
Net Offer (excluding the QIB Portion), subject to exceed ₹200,000 Amount by each Eligible Employee in this
limits prescribed under applicable law portion does not exceed ₹500,000, less Employee
Discount, if any
Bid Lot [●] Equity Shares and in multiples of [●] Equity Shares thereafter
Mode of allotment Compulsorily in dematerialised form
Allotment Lot [●] Equity Shares and in multiples of one Equity Share thereafter
Trading Lot One Equity Share
Who can apply(3) Public financial institutions (as specified in Section 2(72) of the Companies Resident Indian individuals, Eligible NRIs, HUFs Resident Indian individuals, Eligible NRIs and Eligible Employees such that the Bid Amount
Act), scheduled commercial banks, Mutual Funds, Eligible FPIs, VCFs, (in the name of the karta), companies, corporate HUFs (in the name of the karta) does not exceed ₹500,000
AIFs, FVCIs registered with SEBI, multilateral and bilateral development bodies, scientific institutions societies and trusts
financial institutions, state industrial development corporation, insurance and any individuals, corporate bodies and family
companies registered with IRDAI, provident funds (subject to applicable offices including FPIs which are individuals,
law) with minimum corpus of ₹250 million, pension funds with minimum corporate bodies and family offices
corpus of ₹250 million, National Investment Fund set up by the Government
of India, the insurance funds set up and managed by army, navy or air
force of the Union of India, insurance funds set up and managed by the
Department of Posts, India and Systemically Important Non-Banking
Financial Companies.
Terms of Payment In case of Anchor Investors: Full Bid Amount shall be payable by the Anchor Investors at the time of submission of their Bids(4)
In case of all other Bidders: Full Bid Amount shall be blocked by the SCSBs in the bank account of the ASBA Bidder (other than Anchor Investors) or by the Sponsor Bank through the UPI Mechanism, that is specified in
the ASBA Form at the time of submission of the ASBA Form.
Mode of Bidding Only through the ASBA process (except for Anchor Investors). Only through the ASBA process. Only through the ASBA process Only through the ASBA process
* Assuming full subscription in the Offer
(1)
Our Company and the Selling Shareholders may, in consultation with the BRLMs, allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis in accordance with the SEBI ICDR Regulations. One-third of the Anchor Investor Portion shall be reserved for domestic Mutual Funds, subject
to valid Bids being received from domestic Mutual Funds at or above the Anchor Investor Allocation Price. In the event of under-subscription or non-Allotment in the Anchor Investor Portion, the balance Equity Shares in the Anchor Investor Portion shall be added to the Net QIB Portion. For further details,
see “Offer Procedure” on page 355 of the RHP.
(2)
Subject to valid Bids being received at or above the Offer Price. The Offer is being made in terms of Rule 19(2)(b) of the SCRR read with Regulation 45 of the SEBI ICDR Regulations. The Offer is being made through the Book Building Process in accordance with Regulation 6(2) of the SEBI ICDR Regulations,
wherein not less than 75% of the Net Offer shall be available for allocation on a proportionate basis to QIBs. Such number of Equity Shares representing 5% of the Net QIB Portion shall be available for allocation on a proportionate basis to Mutual Funds only. The remainder of the Net QIB Portion shall be available
for allocation on a proportionate basis to QIBs (other than Anchor Investors), including Mutual Funds, subject to valid Bids being received from them at or above the Offer Price. However, if the aggregate demand from Mutual Funds is less than 5% of the Net QIB Portion, the balance Equity Shares available for
allocation in the Mutual Fund Portion will be added to the remaining Net QIB Portion for proportionate allocation to all QIBs. Further, not more than 15% of the Net Offer shall be available for allocation on a proportionate basis to Non-Institutional Bidders and not more than 10% of the Net Offer shall be available
for allocation to RIBs in accordance with the SEBI ICDR Regulations, subject to valid Bids being received from them at or above the Offer Price. Subject to valid Bids being received at or above the Offer Price, under-subscription, if any, in the Non-Institutional Portion or the Retail Portion would be allowed
to be met with spill-over from other categories or a combination of categories at the discretion of our Company and the Selling Shareholders, in consultation with the BRLMs and the Designated Stock Exchange, on a proportionate basis. However, under-subscription, if any, in the QIB Portion will not be
allowed to be met with spill-over from other categories or a combination of categories. Eligible Employees Bidding in the Employee Reservation portion can Bid up to a Bid Amount of ₹500,000. However, a Bid by an Eligible Employee in the Employee Reservation Portion will be considered for allocation, in
the first instance, for a Bid Amount of up to ₹200,000. In the event of undersubscription in the Employee Reservation Portion, the unsubscribed portion will be available for allocation and Allotment, proportionately to all Eligible Employees who have Bid in excess of ₹200,000, subject to the maximum value
of Allotment made to such Eligible Employee not exceeding ₹500,000. Further, an Eligible Employee Bidding in the Employee Reservation Portion can also Bid in the Net Offer and such Bids will not be treated as multiple Bids subject to applicable limits. The unsubscribed portion if any, in the Employee
Reservation Portion shall be added back to the Net Offer. In case of under-subscription in the Net Offer, spill-over to the extent of such under-subscription shall be permitted from the Employee Reservation Portion. For further details, please see “Terms of the Offer” on page 346 of the RHP.
(3)
In the event that a Bid is submitted in joint names, the relevant Bidders should ensure that the depository account is also held in the same joint names and the names are in the same sequence in which they appear in the Bid cum Application Form. The Bid cum Application Form should contain only the name
of the First Bidder whose name should also appear as the first holder of the beneficiary account held in joint names. The signature of only such First Bidder would be required in the Bid cum Application Form and such First Bidder would be deemed to have signed on behalf of the joint holders. Our Company
reserves the right to reject, in its absolute discretion, all or any multiple Bids in any or all categories.
(4)
Anchor Investors shall pay the entire Bid Amount at the time of submission of the Anchor Investor Bid, provided that any positive difference between the Anchor Investor Allocation Price and the Offer Price,shall be payable by the Anchor Investor Pay-in Date as mentioned in the CAN.
ELIGIBLE EMPLOYEES Registered and Corporate Office: S.No. 243/A, Hissa No. 6, CTS No. 4519, 4519/1, Near Chinchwad Station, Chinchwad,
Taluka – Haveli, Pune - 411 019, Maharashtra; Telephone: +91 20 4695 4695 BIDDING IN THE EMPLOYEE
BIDDING UNDER EMPLOYEE
Contact Person: Manisha Chitgopekar, Company Secretary and Compliance Officer; Telephone: +91 20 4695 4695;
RESERVATION PORTION E-mail: cs@krsnadiagnostics.com; Website: www.krsnaadiagnostics.com; Corporate Identity Number: U74900PN2010PLC138068 RESERVATION PORTION
TEAR HERE
To, 100% BOOK BUILT Offer Bid cum
The Board of Directors ISIN: INE08LI01020 Application
KRSNAA DIAGNOSTICS LIMITED LEI: 335800BHDTJRKNTQ1O55 Form No.
Members of the Syndicate STAMP & CODE REGISTERED BROKER / SCSB / CDP / RTA STAMP & CODE 1. NAME & Contact Details of Sole / First BIDDER
Mr. /Ms./M/s.
Address
SUB-BROKER’S / SUB-AGENT’S STAMP & CODE SCSB BRANCH STAMP & CODE
Email
Tel. No. (with STD code) / Mobile
2. PAN of SOLE / FIRST BIDDER
BANK BRANCH SERIAL NO. SCSB SERIAL NO.
3. bidder’s depository account details NSDL CDSL
For NSDL enter 8 digit DP ID followed by 8 digit Client ID / For CDSL enter 16 digit Client ID
PLEASE CHANGE MY BID
4. FROM (as per last Bid or Revision)
Bid No. of Equity Shares Bid Price per Equity Share (`)/ “Cut-off” (Price in multiples of ` 1/- only)
Options (Bids must be in multiples of Bid Lot as advertised) (In Figures Only)
(In Figures) Bid Price Employee Discount Net Price “Cut-off”
8 7 6 5 4 3 2 1 3 2 1 3 2 1 3 2 1 (Please tick)
Option 1
ID
(OR) Option 2
(OR) Option 3
OLD B
5. TO (Revised Bid) (ELIGIBLE EMPLOYEES BIDDING IN THE EMPLOYEE RESERVATION PORTION can Bid at “Cut-off”)
Bid No. of Equity Shares Bid Price per Equity Share (`)/ “Cut-off” (Price in multiples of ` 1/- only)
Options (Bids must be in multiples of Bid Lot as advertised) (In Figures Only)
(In Figures) Bid Price Employee Discount Net Price “Cut-off”
8 7 6 5 4 3 2 1 3 2 1 3 2 1 3 2 1 (Please tick)
ASBA
Bank A/c No.
I/We (on behalf of joint BIDDERS, if any) hereby confirm that I/We have read and understood the terms and conditions of this Bid REVISION Form, the attached ABRIDGED
PROSPECTUS AND THE GENERAL INFORMATION DOCUMENT FOR INVESTING IN PUBLIC ISSUES (“GID”) and hereby agree and confirm the ‘BIDDER’S UNDERTAKING’ AS GIVEN ALONG WITH THE
Bid Cum Application FORM. I/We (on behalf of joint BIDDERS, if any) hereby confirm that I/We have read the Instructions for filling up the Bid REVISION Form given overleaf.
7A. signature OF SOLE/ first bidder 7B. signature OF ASBA BANK ACCOUNT HOLDER(s) MEMBERs OF the SYNDICATE / SUB - SYNDICATE
(As per Bank records) MEMBER / R E G I S T E R E D B roker /
SCSB / CDP / RTA / AGENT STAMP (Acknowledging
I/We authorise the SCSB to do all acts as are necessary to make the application in the Offer. upload of Bid in Stock Exchange system)
1)
2)
Date : ________________, 2021 3)
TEAR HERE
KRSNAA DIAGNOSTICS LIMITED Acknowledgement Slip for Bid cum
Members of the Syndicate / sub-syndicate Application
BID REVISION FORM - Initial Public Member / Registered Broker / SCSB / Form No.
Offer - Eligible employees form CDP / RTA / Agent
PAN of Sole / First Bidder
DPID
/
CLID
Additional Amount Blocked (` in figures) ASBA Bank A/c No. Stamp & Signature of SCSB Branch
Bank Name & Branch
ED BID
REVIS
Received from Mr./Ms./M/s.
Printed by : www.westernpress.in